[From gene to disease: Fanconi anemia]
- PMID: 12661120
[From gene to disease: Fanconi anemia]
Abstract
Fanconi anaemia (FA) is an autosomal recessive hereditary disease featuring diverse clinical symptoms and a cellular hypersensitivity to cross-linking agents. FA patients suffer from developmental abnormalities, progressive anaemia and an increased risk of developing cancer. FA is associated with mutations in one of the group of seven FA genes identified to date. FA genes encode proteins that control a molecular pathway which ensures an adequate defence against certain types of genomic instability and the associated risk of developing cancer. DNA diagnostics is possible.
Similar articles
-
The Fanconi anaemia group G gene FANCG is identical with XRCC9.Nat Genet. 1998 Nov;20(3):281-3. doi: 10.1038/3093. Nat Genet. 1998. PMID: 9806548
-
Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.Hum Mol Genet. 2003 Oct 1;12(19):2503-10. doi: 10.1093/hmg/ddg266. Epub 2003 Aug 5. Hum Mol Genet. 2003. PMID: 12915460
-
Fanconi anemia: a pleotropic mutation with multiple cellular and developmental abnormalities.Ann Genet. 1991;34(3-4):206-11. Ann Genet. 1991. PMID: 1809228 Review.
-
Spectrum of sequence variations in the FANCA gene: an International Fanconi Anemia Registry (IFAR) study.Hum Mutat. 2005 Feb;25(2):142-9. doi: 10.1002/humu.20125. Hum Mutat. 2005. PMID: 15643609
-
Fanconi anaemia and leukaemia - clinical and molecular aspects.Br J Haematol. 2004 Jul;126(2):176-91. doi: 10.1111/j.1365-2141.2004.05023.x. Br J Haematol. 2004. PMID: 15238138 Review.